Straumann 

€113.00
92
+€0.00+0%Friday 20:40

Statistics

Day High
115
Day Low
115
52W High
117
52W Low
79.64
Volume
100
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
0.96%
Dividend
1.09

Upcoming

Dividends

0.96%Dividend Yield
Apr 2026
€1.09
Apr 2025
€0.61
Apr 2025
€0.41
Apr 2024
€0.46
Apr 2024
€0.41
10Y Growth
11.48%
5Y Growth
15.88%
3Y Growth
10.17%
1Y Growth
77.12%

Earnings

Aug 19Expected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
0
0.75
1.5
2.26
Expected EPS
1.974931182
Actual EPS
2.028844

Financials

13.65%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.79BRevenue
381.38MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QS51.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Henry Schein
HSIC
Mkt Cap9.46B
Henry Schein distributes dental products and services, including dental reconstructive products, competing directly with Straumann's dental implants and prosthetics.
DENTSPLY Sirona
XRAY
Mkt Cap1.9B
Dentsply Sirona is a direct competitor in the dental supplies market, offering a wide range of dental products including dental implants and prosthetic solutions.
Align Technology
ALGN
Mkt Cap10.65B
Align Technology, known for its Invisalign system, competes in the dental market by offering orthodontic products that can be alternatives to traditional braces and, indirectly, to dental implants.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet Holdings, while primarily focused on orthopedic reconstructive devices, also offers dental implant and related products, competing in the dental implant market.
Smith & Nephew
SNN
Mkt Cap12.43B
Smith & Nephew, known for its advanced wound management, orthopedics, and other medical devices, competes indirectly by offering products in the reconstructive space, including dental.
Stryker
SYK
Mkt Cap111.95B
Stryker Corporation, a leader in medical technology, offers a range of products that compete in the orthopedics market, which can indirectly affect the market for dental implants and reconstructive solutions.
Danaher
DHR
Mkt Cap163.25B
Danaher Corporation, through its dental segment, provides a broad portfolio of dental products, including dental implants and consumables, directly competing with Straumann.
3M
MMM
Mkt Cap89.91B
3M, through its Health Care business, offers dental products and solutions, including dental adhesives and restoratives, indirectly competing with dental implants and prosthetics.
Envista
NVST
Mkt Cap3.78B
Envista Holdings Corporation, spun off from Danaher, operates in the dental products sector, offering comprehensive dental solutions that compete with Straumann's offerings.

About

Straumann Holding AG is a leading global provider of comprehensive solutions for dental replacement and orthodontic care. The company spans the entire product lifecycle, from research and development to manufacturing and worldwide supply. Its extensive portfolio addresses tooth correction, replacement, restoration, and the prevention of dental issues. Straumann's core offerings include a wide array of dental implant systems—covering both tissue and bone level—crafted from materials like titanium, titanium alloy, and ceramic, alongside specialized mini implants. Complementing these are essential guided and non-guided surgical instruments, as well as diverse implant-borne prosthetics, including ceramic healing and screw-retained abutments. The company also delivers cutting-edge digital dentistry tools, such as intraoral scanners, 3D printers, and milling machines, along with various prevention products. Further expanding its range, Straumann provides advanced biomaterials like bone substitutes, membranes, biologics, and solutions for soft tissue management and oral healing. Digital solutions are tailored for dental labs, practitioners, and centralized milling centers, supporting materials, third-party systems, and guided surgery. Specialized surgical instruments, ranging from modular cassettes to bone block fixation sets, are also key components. For edentulous patients, comprehensive options like Pro Arch fixed and mini implant solutions are available. Esthetic restorations, featuring ceramic implants and abutments, are emphasized, as are wound-healing products like Emdogain, and orthodontic solutions such as Clear Correct aligners. Beyond products, Straumann invests in customer education through training services. Its products reach a diverse global clientele, including general dentists, specialists, dental technicians, laboratories, and corporate customers like distributors, hospitals, universities, and dental service organizations. Operating in approximately 100 countries, the company leverages a robust network of distribution subsidiaries and partners. Straumann Holding AG was established in Basel, Switzerland, in 1954.
Show More
CEO
Guillaume Daniellot
Employees
11342
Country
Switzerland
ISIN
CH1175448666
WKN
000A3DHHH

Listings

0 Comments

Share your thoughts

FAQs

What is Straumann stock price today?▼
The current price of QS51.F is €113.00 EUR — it has increased by +0% in the past 24 hours. Watch Straumann stock price performance more closely on the chart.
What is Straumann stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Straumann stocks are traded under the ticker QS51.F.
Is Straumann stock price growing?▼
QS51.F stock has risen by +8.65% compared to the previous week, the month change is a +16.49% rise, over the last year Straumann has showed a +12.44% increase.
When is the next Straumann earnings date?▼
Straumann is going to release the next earnings report on February 24, 2027.
What were Straumann earnings last quarter?▼
QS51.F earnings for the last quarter are 1.74 EUR per share, whereas the estimation was 1.69 EUR resulting in a +2.73% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Straumann revenue for the last year?▼
Straumann revenue for the last year amounts to 2.79B EUR.
What is Straumann net income for the last year?▼
QS51.F net income for the last year is 381.38M EUR.
Does Straumann pay dividends?▼
Yes, QS51.F dividends are paid annual. The last dividend per share was 1.09 . As of today, Dividend Yield (FWD)% is 0.96%.
How many employees does Straumann have?▼
As of November 7, 2026, the company has 11,342 employees.
In which sector is Straumann located?▼
Straumann operates in the Health & Wellness sector.
When did Straumann complete a stock split?▼
The last stock split for Straumann was on April 20, 2022 with a ratio of 10:1.
Where is Straumann headquartered?▼
Straumann is headquartered in Basel, Switzerland.